Proprietary Drug Index

Trinity Life Sciences has introduced a proprietary AI algorithm that accurately forecasted commercial outcomes for over 90% of U.S. drug launches since 2014, significantly outperforming Wall Street analysts, who averaged less than 60% accuracy.